Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

With cladribine gone, Gilenya takes center stage
Fierce Pharma
Wednesday, June 22, 2011 - 7:35pm
tags:
Gilenya, cladribine, Movectro, MS, multiple sclerosis, Novartis, Merck KGaA
Building on Pfizer's Blockbuster
Motley Fool
Wednesday, June 22, 2011 - 7:33pm
tags:
Pfizer, Lyrica
Teva's Dividend Is Safe
Motley Fool
Wednesday, June 22, 2011 - 7:33pm
tags:
Teva Pharmaceuticals, dividends
Neurocrine Biosciences: Solid Financials, Strong Pipeline
Seeking Alpha
Wednesday, June 22, 2011 - 7:32pm
tags:
Neurocrine, Abbott Laboratories, GSK
Achillion jumps 11% on stock offer pricing
Marketwatch
Wednesday, June 22, 2011 - 10:30am
tags:
stock offering, Achillion
Vivus' ED Drug on Track
Yahoo/Zacks.com
Wednesday, June 22, 2011 - 10:29am
tags:
Vivus, Avanafil, erectile dysfunction, GSK, Pfizer, Viagra, Levitra
Fibrocell Receives FDA Approval for LaViv
TheStreet.com
Wednesday, June 22, 2011 - 9:04am
tags:
laViv, FDA, Fibrocell Science, dermal fillers
FDA votes against Novartis gout drug: WSJ
Marketwatch
Wednesday, June 22, 2011 - 9:03am
tags:
FDA, advisory panels, Novartis, gout, Ilaris
Shire's Firazyr effective for hereditary angiodema, FDA says
Pharma Times, UK
Wednesday, June 22, 2011 - 8:18am
tags:
Shire, Firazyr, FDA, hereditary angiodema
Merck KGaA Slides After Decision Not to Seek MS Drug Approval
Bloomberg
Wednesday, June 22, 2011 - 8:16am
tags:
MS, multiple sclerosis, Merck KGaA, cladribine
Biotech Clinical Trials Update: CRIS, ALKS, CHTP
Seeking Alpha
Wednesday, June 22, 2011 - 8:14am
tags:
clinical trials, ALKS 5461, depression, Alkermes, Northera, Chelsea Therapeutics, Multimeric-001, flu vaccine
Johnson & Johnson Attracts Call-Buyers
TheStreet.com
Wednesday, June 22, 2011 - 8:12am
tags:
JNJ, call options
AstraZeneca sells dental business to Dentsply for $1.8 billion
Yahoo/AP
Wednesday, June 22, 2011 - 8:11am
tags:
Dentsply, M&A, AstraZeneca, Astra Tech
Forest Fights Back Against Icahn in Filing
Motley Fool
Tuesday, June 21, 2011 - 9:54pm
tags:
Carl Icahn, Forest Labs
Pfizer pain treatment Lyrica shows promise in early results of late-stage study
Yahoo/AP
Tuesday, June 21, 2011 - 9:54pm
tags:
Lyrica, Pfizer, painkillers
High Doses of Cholesterol Drugs Raise Diabetes Risk in Study
Bloomberg
Tuesday, June 21, 2011 - 9:53pm
tags:
diabetes, Pfizer, AstraZeneca, statins, Crestor, Lipitor
Rheumatoid Arthritis Drugs May Help Curb Diabetes Development
Bloomberg
Tuesday, June 21, 2011 - 9:51pm
tags:
diabetes, rheumatoid arthritis, Remicade, Humira, Abbott Laboratories, Amgen, Enbrel
Is Johnson & Johnson a Stock for the Long Term?
Motley Fool
Tuesday, June 21, 2011 - 9:49pm
tags:
JNJ
Best Healthcare Sector Dividend Stocks
Seeking Alpha
Tuesday, June 21, 2011 - 9:48pm
tags:
dividends, AstraZeneca, Bristol-Myers Squibb, Trinity Biotech
Spectrum's Fusilev Supply Edge Easing
TheStreet.com
Tuesday, June 21, 2011 - 11:04am
tags:
Fusilev, Spectrum Pharmaceuticals, leucovorin, colon cancer, Teva Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.